{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:16:39Z","timestamp":1788444999026,"version":"build-2803163510"},"reference-count":21,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"unspecified","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,8,25]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The hepatitis C virus (HCV) is a significant healthcare burden across the globe and is a major cause of liver malignancies. However, patients with serious mental illness (SMI) living with HCV are disproportionately affected and underserved within the current care framework. A previous meta-analysis on this topic yielded a prevalence of 8%, which is considerably higher than that observed in the broader population. Since the original review was published in early 2022, an update is required to incorporate data published during and after the COVID-19 pandemic and to evaluate its effect on overall prevalence and care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>\n                      This systematic review and meta-analysis will replicate the methodology of the original review. To ensure a thorough investigation, a systematic search strategy will be implemented across PubMed, Google Scholar, Scopus, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Embase and Web of Science to include studies published from 2 July 2020 to 22 June 2026. The review will include prospective observational and retrospective cross-sectional studies conducted among adults aged over 18 years with a verified SMI diagnosis and laboratory-confirmed HCV status. A dual-reviewer protocol will be employed to evaluate all retrieved titles, abstracts and full-text manuscripts to ensure unbiased selection. Any disagreements will be adjudicated by a third senior investigator. Methodological rigour will be assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Prevalence Studies Quality Assessment Tool for Systematic Reviews of Observational Studies. This validated instrument will ensure transparency and standardised quality assessment and will be supplemented by a customised 3-point global assessment. A Generalised Linear Mixed Model (GLMM) with a logit transformation will be used for the meta-analytical synthesis to effectively account for expected heterogeneity and extreme proportions, while the degree of inconsistency across studies will be quantified using the I\n                      <jats:sup>2<\/jats:sup>\n                      statistic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Formal ethical clearance is not required for this study, as it relies entirely on the synthesis of secondary data from published articles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD420261331799.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-119668","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:45:17Z","timestamp":1788443117000},"page":"e119668","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Pooled prevalence, risk factors and barriers to care for hepatitis C virus (HCV) in adults with serious mental illness (SMI): an updated systematic review and meta-analysis \u2013 protocol"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0672-4791","authenticated-orcid":false,"given":"Saba","family":"Maryam","sequence":"first","affiliation":[{"name":"Department of Community Medicine & Public Health, Rawalpindi Medical University, Rawalpindi, Pakistan"},{"name":"MBBS, Rawalpindi Medical University, Rawalpindi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8036-5446","authenticated-orcid":false,"given":"Mehreen","family":"Noor","sequence":"additional","affiliation":[{"name":"Department of Community Medicine & Public Health, Rawalpindi Medical University, Rawalpindi, Pakistan"},{"name":"Rawalpindi Medical University, Rawalpindi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afifa","family":"Kulsoom","sequence":"additional","affiliation":[{"name":"Department of Community Medicine & Public Health, Rawalpindi Medical University, Rawalpindi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"2026090306451105000_16.9.e119668.1","unstructured":"Hepatitis C. 2026. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c"},{"key":"2026090306451105000_16.9.e119668.2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026090306451105000_16.9.e119668.3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S2215-0366(15)00357-0","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness: a systematic review and meta-analysis","volume":"3","author":"Hughes","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"2026090306451105000_16.9.e119668.4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2105\/AJPH.91.1.38","article-title":"Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?","volume":"91","author":"Hope","year":"2001","journal-title":"Am J Public Health"},{"key":"2026090306451105000_16.9.e119668.5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.gastre.2022.06.005","article-title":"Prevalence of hepatitis C virus infection in patients with chronic mental disorders: The relevance of dual disorders","volume":"46","author":"Roncero","year":"2023","journal-title":"Gastroenterolog\u00eda y Hepatolog\u00eda (English Edition)"},{"key":"2026090306451105000_16.9.e119668.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61097-0"},{"key":"2026090306451105000_16.9.e119668.7","unstructured":"Management of physical health condition in adults with severe mental disorders. 2018. Available: https:\/\/www.who.int\/publications\/i\/item\/9789241550383"},{"key":"2026090306451105000_16.9.e119668.8","unstructured":"Hepatitis C among drug users in Europe: epidemiology, treatment and prevention. The European Union Drugs Agency (EUDA); 2026. Available: https:\/\/www.euda.europa.eu\/publications\/insights\/hepatitis-c-among-drug-users-in-europe_en"},{"key":"2026090306451105000_16.9.e119668.9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S2215-0366(19)30132-4","article-title":"The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness","volume":"6","author":"Firth","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"2026090306451105000_16.9.e119668.10","unstructured":"Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. 2026. Available: https:\/\/www.who.int\/publications\/i\/item\/9789241550345"},{"key":"2026090306451105000_16.9.e119668.11","doi-asserted-by":"crossref","first-page":"E583","DOI":"10.1503\/jpn.200154","article-title":"Hepatitis C-associated late-onset schizophrenia: a nationwide, population-based cohort study","volume":"46","author":"Cheng","year":"2021","journal-title":"J Psychiatry Neurosci"},{"key":"2026090306451105000_16.9.e119668.12","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1365-2036.2010.04460.x","article-title":"Barriers to accessing care in patients with chronic hepatitis C: the impact of depression","volume":"32","author":"Evon","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"2026090306451105000_16.9.e119668.13","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf237","article-title":"Hepatitis C Treatment Initiation During Hospitalization for People Who Use Drugs: A Narrative Review of the Literature","volume":"12","author":"Denkins","year":"2025","journal-title":"Open Forum Infect Dis"},{"key":"2026090306451105000_16.9.e119668.14","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.21r14079","article-title":"Determinants of Hepatitis C Virus Prevalence in People With Serious Mental Illness: A Systematic Review and Meta-Analysis","volume":"83","author":"Braude","year":"2021","journal-title":"J Clin Psychiatry"},{"key":"2026090306451105000_16.9.e119668.15","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.amepre.2023.06.016","article-title":"Hepatitis C Cascade of Care in the Direct-Acting Antivirals Era: A Meta-Analysis","volume":"65","author":"Hernandez-Con","year":"2023","journal-title":"Am J Prev Med"},{"key":"2026090306451105000_16.9.e119668.16","unstructured":"Accelerating the elimination of viral hepatitis. 2026. Available: https:\/\/www.thelancet.com\/commissions-do\/elimination-of-viral-hepatitis"},{"key":"2026090306451105000_16.9.e119668.17","unstructured":"Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. 2026. Available: https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06"},{"key":"2026090306451105000_16.9.e119668.18","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2026090306451105000_16.9.e119668.19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/1941126X.2018.1444339","article-title":"Rayyan for systematic reviews","volume":"30","author":"Johnson","year":"2018","journal-title":"J Electr Resour Librariansh"},{"key":"2026090306451105000_16.9.e119668.20","first-page":"229","article-title":"What Quality Assessment Tool Should I Use? A Practical Guide for Systematic Reviews Authors","volume":"48","author":"Delavari","year":"2023","journal-title":"Iran J Med Sci"},{"key":"2026090306451105000_16.9.e119668.21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v106.i02","article-title":"netmeta: an R package for network meta-analysis using frequentist methods","volume":"106","author":"Balduzzi","year":"2023","journal-title":"J Stat Soft"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-119668","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:45:20Z","timestamp":1788443120000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-119668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,3]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjopen-2026-119668"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-119668","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}